Clin2
NCT07447206Possibly a fitNot yet recruiting

Blood pressure and cholesterol treatment for Alzheimer's prevention

HypertensionHypercholesterolemiaDementia Risk Factors

Treatments studied

Part of Heart & circulation, Hormones & metabolism clinical trials.

This study tests whether actively lowering blood pressure and cholesterol can slow down or prevent memory decline in people who carry a genetic risk for Alzheimer's disease. It aims to see if these treatments can help keep your brain healthy as you age.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 2
Enrollment
10 people
Ages
50 years to 75 years
Study type
Interventional

Who can take part

  • You must be between 50 and 75 years old.
  • You must carry a specific gene variant called APOE ε4 (a genetic risk factor for Alzheimer's).
  • Your LDL ('bad') cholesterol must be between 100 and 250 mg/dL, and your systolic blood pressure (the top number) must be between 130 and 180 mm Hg.
  • You must not have dementia or be taking any medications for dementia.
  • You must be able to speak English fluently.
  • If you are a woman, you must be post-menopausal (no periods for at least a year).

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT05106036Recruiting
Lowering BP targets to prevent memory and thinking decline

This study tests whether setting a lower blood pressure goal can help prevent future memory and thinking problems in older adults. It compares a more intensive blood pressure plan with usual care to see if it better protects the brain over time.

Dallas, Texas
NCT06507254Recruiting
Polyphenols and brain health in aging

This study tests whether eating more polyphenols (natural compounds in plants) can protect brain health in people at higher risk for Alzheimer's disease, especially if they currently eat a typical Western diet. Participants will be followed over time to see if changes in diet affect thinking and memory.

Los Angeles, California
NCT07605130Not yet recruiting· Phase 4
Brain training and cholesterol lowering for narrowed brain arteries

This study tests two approaches together: a computer-based brain training program and a stronger cholesterol-lowering medicine, to see if they can help improve memory and thinking in people with narrowed brain arteries. You would be randomly assigned to different combinations of the two, and the doctors will monitor your progress.

Beijing, Beijing Municipality
NCT02472028Recruiting· Phase 4
Lower blood pressure to protect the brain in older adults

This study tests whether better blood pressure control can slow changes seen on brain scans in older people. It focuses on people with high blood pressure and “wear-and-tear” type brain lesions on MRI.

Bordeaux, Pellegrin Hospital Group
NCT04601038Recruiting· Phase 2
Testing a stress-blocking drug for early Alzheimer's risk

This study tests a new medication, CORT108297, that may help protect the brain from the harmful effects of stress in people at risk for Alzheimer's disease. It is looking for adults age 55 and older who either have mild memory problems or are healthy but have a family history, APOE4 gene, or memory concerns.

Baltimore, Maryland
NCT06417086Recruiting
Acupuncture for Alzheimer's in gene carriers and non-carriers

This trial tests whether acupuncture can help people with Alzheimer's disease. Researchers will compare results in people who carry the APOE e4 gene and those who don't, to see if the treatment works differently.

Shanghai

Hear when a new High blood pressure trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.